Literature DB >> 28589557

Does a blood pressure J curve exist for patients with chronic kidney disease?

Nicolás Roberto Robles1, Roman Hernandez-Gallego2, Francesco Fici3, Guido Grassi4.   

Abstract

Aggressive reduction of blood pressure may increase cardiovascular events (the J-curve phenomenon) in certain populations. In this regard, most studies in patients with chronic kidney disease have shown a J curve for cardiovascular morbidity and mortality, and this phenomenon persists after adjusting for confounding factors. Since there is no evidence that a straighter blood pressure target (<130/70 mm Hg) could improve renal outcomes, the increased cardiovascular risk associated with extreme blood pressure reduction should be seen as undesirable. Moreover, the intensive control of blood pressure may induce an unintended reduction of renal function and this decrease, in turn, may increase cardiovascular risk. ©2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  J curve; chronic kidney disease; hypertension

Mesh:

Substances:

Year:  2017        PMID: 28589557      PMCID: PMC8030777          DOI: 10.1111/jch.13024

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  60 in total

1.  Intensive blood-pressure control in hypertensive chronic kidney disease.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta L Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

2.  Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.

Authors:  Piero Ruggenenti; Annalisa Perna; Giacomina Loriga; Maria Ganeva; Bogdan Ene-Iordache; Marta Turturro; Maria Lesti; Elena Perticucci; Ivan Nediyalkov Chakarski; Daniela Leonardis; Giovanni Garini; Adalberto Sessa; Carlo Basile; Mirella Alpa; Renzo Scanziani; Gianbattista Sorba; Carmine Zoccali; Giuseppe Remuzzi
Journal:  Lancet       Date:  2005 Mar 12-18       Impact factor: 79.321

3.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

Review 4.  Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier.

Authors:  Ashish Upadhyay; Amy Earley; Shana M Haynes; Katrin Uhlig
Journal:  Ann Intern Med       Date:  2011-03-14       Impact factor: 25.391

5.  Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality.

Authors:  Roberto Pastor-Barriuso; José R Banegas; Javier Damián; Lawrence J Appel; Eliseo Guallar
Journal:  Ann Intern Med       Date:  2003-11-04       Impact factor: 25.391

6.  Reverse J-curve relation between diastolic blood pressure and severity of coronary artery lesion in hypertensive patients with angina pectoris.

Authors:  Naoyuki Hasebe; Shinsuke Kido; Akira Ido; Kikuchi Kenjiro
Journal:  Hypertens Res       Date:  2002-05       Impact factor: 3.872

Review 7.  The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?

Authors:  Franz H Messerli; Gurusher S Panjrath
Journal:  J Am Coll Cardiol       Date:  2009-11-10       Impact factor: 24.094

8.  Level of blood pressure and risk of myocardial infarction among treated hypertensive patients.

Authors:  L W McCloskey; B M Psaty; T D Koepsell; G N Aagaard
Journal:  Arch Intern Med       Date:  1992-03

9.  Systolic blood pressure as an independent predictor of mortality in the Hypertension Detection and Follow-up Program.

Authors:  J Abernethy; N O Borhani; C M Hawkins; R Crow; G Entwisle; J W Jones; M H Maxwell; H Langford; S Pressel
Journal:  Am J Prev Med       Date:  1986 May-Jun       Impact factor: 5.043

10.  Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease.

Authors:  Elaine Ku; David V Glidden; Kirsten L Johansen; Mark Sarnak; Hocine Tighiouart; Barbara Grimes; Chi-Yuan Hsu
Journal:  Kidney Int       Date:  2014-12-10       Impact factor: 10.612

View more
  4 in total

Review 1.  J-shaped curve for cardiovascular mortality: systolic or diastolic blood pressure?

Authors:  Nicolás Roberto Robles; Francesco Fici; Guido Grassi
Journal:  J Nephrol       Date:  2018-09-17       Impact factor: 3.902

Review 2.  Does a blood pressure J curve exist for patients with chronic kidney disease?

Authors:  Nicolás Roberto Robles; Roman Hernandez-Gallego; Francesco Fici; Guido Grassi
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-06-07       Impact factor: 3.738

3.  Blood pressure target for hypertension in chronic kidney disease: One size does not fit all.

Authors:  Anastasios Kollias; Konstantinos G Kyriakoulis; George S Stergiou
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-05-03       Impact factor: 3.738

4.  Blood pressure components and incident cardiovascular disease and mortality events among Iranian adults with chronic kidney disease during over a decade long follow-up: a prospective cohort study.

Authors:  Ashkan Hashemi; Sormeh Nourbakhsh; Samaneh Asgari; Mohammadhassan Mirbolouk; Fereidoun Azizi; Farzad Hadaegh
Journal:  J Transl Med       Date:  2018-08-15       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.